| Net Cash Provided by (Used in) Operating Activities |
$29,571,000 |
USD |
40% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$27,319,000 |
USD |
49% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$11,629,000 |
USD |
-45% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
110,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
48,482,000 |
shares |
6.5% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$13,881,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$14,387,000 |
USD |
53% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$7,812,000 |
USD |
-20% |
Q1 2025 |
Q1 2025 |
| Operating Lease, Liability |
$2,580,000 |
USD |
-5.9% |
Q4 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$114,639,000 |
USD |
29% |
Q4 2025 |
FY 2025 |
| Additional Paid in Capital |
$1,189,846,000 |
USD |
9.9% |
Q4 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$9,162,000 |
USD |
0.74% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$729,000 |
USD |
|
Q4 2025 |
FY 2025 |
| Interest Expense |
$47,450,000 |
USD |
36% |
Q1 2024 |
Q1 2024 |